Resolved: Targeting a higher hemoglobin is associated with greater risk in patients with CKD anemia: con.
Himmelfarb
Jonathan
J
Kidney Research Center, University of Washington, Seattle, Washington 98104, USA. himmej@u.washington.edu
Szczech
Lynda Anne
LA
D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology*; D002318:Cardiovascular Diseases / Q000453:epidemiology*; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D006400:Hematocrit; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D007674:Kidney Diseases / Q000097:blood / Q000150:complications*; D012307:Risk Factors
D006454:Hemoglobins; D004921:Erythropoietin